Fig. 7

TRIM44 mediates the effects of KLF9 on DR pathology. (A) Cell viability was assessed in RMECs by MTT assay. (B) Cell migration ability in RMECs was detected by wound healing assay (magnification ×100). (C) Angiogenesis assay was carried out to assess the tube formation in RMECs (magnification ×100). The quantification of (B) the percentage of wound-healing rate and (E) the number of tube formations were exhibited. *P < 0.05; **P < 0.01. n = 3 per group